SOLTF
Price
$6.40
Change
-$0.35 (-5.19%)
Updated
Sep 26 closing price
Capitalization
599.82M
SPHRF
Price
$0.10
Change
+$0.02 (+25.00%)
Updated
Aug 26 closing price
Capitalization
60.6M
Interact to see
Advertisement

SOLTF vs SPHRF

Header iconSOLTF vs SPHRF Comparison
Open Charts SOLTF vs SPHRFBanner chart's image
Nxera Pharma
Price$6.40
Change-$0.35 (-5.19%)
Volume$100
Capitalization599.82M
Starpharma Holdings
Price$0.10
Change+$0.02 (+25.00%)
Volume$23.82K
Capitalization60.6M
SOLTF vs SPHRF Comparison Chart in %
Loading...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SOLTF vs. SPHRF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOLTF is a Hold and SPHRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (SOLTF: $6.40 vs. SPHRF: $0.10)
Brand notoriety: SOLTF and SPHRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SOLTF: 9% vs. SPHRF: 132%
Market capitalization -- SOLTF: $599.82M vs. SPHRF: $60.6M
SOLTF [@Biotechnology] is valued at $599.82M. SPHRF’s [@Biotechnology] market capitalization is $60.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SOLTF’s FA Score shows that 0 FA rating(s) are green whileSPHRF’s FA Score has 1 green FA rating(s).

  • SOLTF’s FA Score: 0 green, 5 red.
  • SPHRF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHRF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 5 TA indicator(s) are bullish while SPHRF’s TA Score has 2 bullish TA indicator(s).

  • SOLTF’s TA Score: 5 bullish, 6 bearish.
  • SPHRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, both SOLTF and SPHRF are a good buy in the short-term.

Price Growth

SOLTF (@Biotechnology) experienced а -11.11% price change this week, while SPHRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($600M) has a higher market cap than SPHRF($60.6M). SPHRF YTD gains are higher at: 33.970 vs. SOLTF (3.938). SOLTF has higher annual earnings (EBITDA): 854M vs. SPHRF (-13.7M). SOLTF has higher revenues than SPHRF: SOLTF (31.2B) vs SPHRF (2.98M).
SOLTFSPHRFSOLTF / SPHRF
Capitalization600M60.6M990%
EBITDA854M-13.7M-6,233%
Gain YTD3.93833.97012%
P/E RatioN/AN/A-
Revenue31.2B2.98M1,046,980%
Total Cash33BN/A-
Total Debt64.7BN/A-
FUNDAMENTALS RATINGS
SOLTF vs SPHRF: Fundamental Ratings
SOLTF
SPHRF
OUTLOOK RATING
1..100
8644
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
5442
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
33n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHRF's Valuation (31) in the null industry is somewhat better than the same rating for SOLTF (91). This means that SPHRF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

SPHRF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SPHRF’s stock grew similarly to SOLTF’s over the last 12 months.

SPHRF's SMR Rating (97) in the null industry is in the same range as SOLTF (99). This means that SPHRF’s stock grew similarly to SOLTF’s over the last 12 months.

SPHRF's Price Growth Rating (42) in the null industry is in the same range as SOLTF (54). This means that SPHRF’s stock grew similarly to SOLTF’s over the last 12 months.

SPHRF's P/E Growth Rating (100) in the null industry is in the same range as SOLTF (100). This means that SPHRF’s stock grew similarly to SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SOLTFSPHRF
RSI
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
41%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
41%
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
41%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
32%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
Bullish Trend 10 days ago
55%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
43%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
57%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
26%
Bullish Trend 3 days ago
14%
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAGRX133.770.82
+0.62%
Permanent Portfolio Aggressive Growth I
TSHIX15.850.07
+0.44%
Transamerica Multi-Asset Income I
RPXIX31.300.04
+0.13%
RiverPark Large Growth Institutional
FLCOX19.91N/A
N/A
Fidelity Large Cap Value Index
INKDX18.98N/A
N/A
Victory Pioneer Disciplined Growth R6

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
-5.19%
BIESF - SOLTF
35%
Loosely correlated
N/A
XTLB - SOLTF
24%
Poorly correlated
-1.68%
SPHRF - SOLTF
22%
Poorly correlated
N/A
ATON - SOLTF
20%
Poorly correlated
-7.68%
SLNCF - SOLTF
9%
Poorly correlated
N/A
More

SPHRF and

Correlation & Price change

A.I.dvisor tells us that SPHRF and SYBX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and SYBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
SYBX - SPHRF
29%
Poorly correlated
+4.82%
SPHRY - SPHRF
26%
Poorly correlated
N/A
SOLTF - SPHRF
23%
Poorly correlated
-5.19%
RNXT - SPHRF
22%
Poorly correlated
+0.85%
PYPD - SPHRF
21%
Poorly correlated
-1.04%
More